Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Dimerix Limited
  6. News
  7. Summary
    DXB   AU000000DXB7

DIMERIX LIMITED

(DXB)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Dimerix : Extends COVID-19 Study Across Europe

08/02/2021 | 06:43am EST


© MT Newswires 2021
All news about DIMERIX LIMITED
10/21DIMERIX : Secures Ethics, Regulatory Approval for Phase 3 Kidney Disease Trial in Australi..
MT
10/20Dimerix Limited Announces First Approvals Received for Start of Phase 3 FSGS Trial
CI
10/15DIMERIX : Expands Phase 3 Study for COVID-19 Drug to Australia; Shares Rise 4%
MT
10/14Dimerix Limited Announces Phase 3 DMX-200 Covid-19 Study Expands into Australia
CI
10/01DIMERIX : to Raise $3 Million in Oversubscribed Share Purchase Plan
MT
09/24DIMERIX : India's Drug Regulator Approves Dimerix's COVID-19 Drug Clinical Study
MT
09/23Dimerix Limited Recommends DMX-200 Clinical Study in COVID-19 Patients
CI
08/24DIMERIX : Starts Phase Three Study for Kidney Patients; Shares Jump 8%
MT
08/24Dimerix Limited Announces Phase 3 Study in FSGS Kidney Patients Commences
CI
08/15DIMERIX : Widens Net Loss in FY21; Shares Surge 43%
MT
More news
Financials
Sales 2021 4,44 M 3,11 M 3,11 M
Net income 2021 -6,37 M -4,46 M -4,46 M
Net cash 2021 0,16 M 0,11 M 0,11 M
P/E ratio 2021 -6,06x
Yield 2021 -
Capitalization 72,2 M 50,7 M 50,6 M
EV / Sales 2020 26,7x
EV / Sales 2021 8,66x
Nbr of Employees -
Free-Float 91,5%
Chart DIMERIX LIMITED
Duration : Period :
Dimerix Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DIMERIX LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
Nina Webster Chief Executive Officer, MD & Director
Hamish George Chief Financial Officer & Secretary
James Howard Williams Non-Executive Chairman
David Packham Chief Medical Officer
Robert Shepherd Director-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
DIMERIX LIMITED2.13%51
MODERNA, INC.193.60%124 359
LONZA GROUP AG25.98%58 058
IQVIA HOLDINGS INC.46.05%49 991
SEAGEN INC.-13.93%27 564
CELLTRION, INC.-41.36%24 298